D-0102-2024 Class I Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- November 15, 2023
- Initiation Date
- October 2, 2023
- Termination Date
- February 14, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,200 vials
Product Description
2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4903-11
Reason for Recall
Presence of Particulate Matter: identified as glass.
Distribution Pattern
Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.
Code Information
Lot#: GH6567, Exp. 7/1/2024